The role of polymorphism of the genes COL1A1, MMP12, EPHX1 in osteoarthritis and cardiovascular comorbidity
Year: 2018, volume 14 Issue: №3 Pages: 373-379
Heading: Internal Diseases Article type: Original article
Authors: Kabalyk M.A., Nevzorova V.A., Sunyaykin А.В.
Organization: Pacific State Medical University
Heading: Internal Diseases Article type: Original article
Authors: Kabalyk M.A., Nevzorova V.A., Sunyaykin А.В.
Organization: Pacific State Medical University
Summary:
Aim: to analyze polymorphic variants of genes of connective tissue remodeling, biotransformation and their role in the development of cardiovascular comorbidity and osteoarthritis (OA). Material and Methods. The study included 70 patients with OA. As a control group, 30 patients without OA of comparable sex and age were included in the study. All patients were assessed total (absolute) cardiovascular risk according to the SCORE scale. The pain was assessed by visual analog pain scale. The physical dysfunction was assessed on a WOMAC scale. Single-nucleotide polymorphisms of the genes COL1A1 (rs1107946), EPHX1 (rs1051740), MMP12 (rs652438) were studied by PCR-RT. Results. In patients with OA, there is a twofold increase in the frequency of the heterozygous genotype of the GT gene COL1A1. The presence of the T allele of the COL1A1 gene is a risk factor for the development of OA. Patients with OA have a fourfold increase in the frequency of genotype AG of the MMP12 gene. The patients with severe pain significantly present the difference in the distribution of allele frequencies of the polymorphic locus G1997T of the COL1A1 gene from the control sample. The frequencies of heterozygous genotypes COL1A1 and MMP12 differed significantly in patients with different cardiovascular risk. Conclusion. The results partially confirm the integration theory of the pathogenesis of OA, suggest the existence of general mechanisms of connective tissue remodeling.
Bibliography:
1. KrausVB, Blanco FJ, Englund M,etal. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthritis Cartilage 2015; 238: 1233-41
2. Findlay DM. Vascular pathology and osteoarthritis. Rheumatology (Oxford) 2007; 46 (12): 1763-8
3. Kabalyk MA. Molecular relationships of vascular remodeling in patients with osteoarthritis with arterial hypertension. Bulletin of modern clinical medicine 2017; 10 (5): 29-35
4. Tanner RM, Lynch Al, et al. Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patient
s with hypertension. PLoS One 2011; 6 (8): e23609
5. Lv FJ, Peng Y, Lim FL, et al. Matrix metalioproteinase 12 is an indicator of intervertebral disc degeneration co-expressed with fibrotic markers. Osteoarthritis Cartilage 2016; 24 (10): 1826-36
6. Davidson RK, Waters JG, Kevorkian L, et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 2006; 8 (4): R124
7. Su L, Zhou W, Asomaning K, et al. Genotypes and haplotypes of matrix metalioproteinase 1, 3 and 12 genes and the risk of lung cancer. Carcinogenesis 2006; 27 (5): 1024-9
8. Biatecka M, Kurzawski M, Vlaykova T, et al. Effects of common functional MMP12 gene polymorphisms on PD in a Polish population. Neurol Neurochir Pol 2017; 51 (5): 347-53
9. Xie P, Liu B, Zhang L, et al. Association of COL1A1 polymorphisms with osteoporosis: a meta-analysis of clinical studies. Int J Clin Exp Med. 2015; 8 (9): 14764-14781
10. Prockop DJ, Kivirikko Kl. Collagens: molecular biology diseases, and potentials for therapy. Annu Rev Biochem 1995; 64: 403-34
11. Blackstock CD, Higashi Y, Sukhanov S, et al. Insulinlike growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5'stem-loop of COL1a1 and COL1a2mRNA. J Biol Chem 2014; 289 (11): 7264-74
12. Tsezou A. Osteoarthritis year in review 2014: genetics and genomics. Osteoarthritis Cartilage 2014; 22 (12): 2017-24
13. Vafaie F, Yin H, O'Neil C, et al. Collagenase-resistant collagen promotes mouse aging and vascular cell senescence. Aging Cell 2014; 13(1): 121-30
14. Chang SW, Shefelbine SJ, Buehler MJ. Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease. Biophys J 2012; 102 (3): 640-8
15. Garcia-Giralt N, Nogue's X, Enjuanes A, et al. Two new single-nucleotide polymorphisms in the COL1A1 upstream regulatory region and their relationship to bone mineral density. J Bone Miner Res 2002; 17: 384-93
16. Jin H, Evangelou E, loannidis JPA, Ralston SH. Polymorphisms in the 5'flank of COL1A1 gene and osteoporosis: meta-analysis of published studies. Osteporos Int 2011; 22 (3): 911-21
17. Yazdanpanah N, Rivadeneira F, van Meurs JB, et al. The -1997 G/T and Sp1 polymorphisms in the collagen type I alphal (COLIA1) gene in relation to changes in femoral neck bone mineral density and the risk of fracture in the elderly: the Rotterdam study. Calcif Tissue Int 2007; 81 (1): 18-25
18. Saini P, Wani SI, Kumar R, et al. Trigger factor assisted folding of the recombinant epoxide hydrolases identified from С pelagibacter and S. nassauensis. Protein Expr Purif 2014; 104: 71-84
19. Yang X, Wang Y, Wang G. Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects. J Exp Clin Cancer Res 2014; 33:82
20. Akparova A, Abdrakhmanova B, Banerjee N, Bersimbaev R. EPHX1 Y113H polymorphism is associated with increased risk of chronic obstructive pulmonary disease in Kazakhstan population. Mutat Res Genet Toxicol Environ Mutagen 2017; 816-817: 1-6
21. Sirish P, Li N, Liu JY, et al. Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis. Proc Natl Acad Sci USA 2013; 110 (14): 5618-23
22.BackmanJT,Sieglel,ZangerUM.,FritzP.lmmunohistochemical detection of microsomal epoxide hydrolase in human synovial tissue. Histochem J 1999; 31 (10): 645^19
23. Amat M, Diaz C, Vila L. Leukotriene A4 hydrolase and leukotriene C4 synthase activities in human chondrocytes: transcellular biosynthesis of Leukotrienes during granulocyte-chondrocyte interaction. Arthritis Rheum 1998; 41 (9): 1645-51
24. Zajceva EM, Smirnov AV, Alekseeva LI. Assessment of bone mineral density of subchondral sections of the hip and tibia in gonarthrosis. Scientific and Practical Rheumatology 2005; 1: 27-30
25. Yu FY, Yang SC, Ji ES. The role of adventitia in hypoxic vascular remodeling. Sheng Li Xue Bao 2018; 70 (2): 211-6
26. Zhang L, Yang M, Yang D, et al. Molecular interactions of MMP-13 C-terminal domain with chondrocyte proteins. Connect Tissue Res 2010; 51 (3): 230-9.
| Attachment | Size |
|---|---|
| 2018_3_373-379.pdf | 291.79 KB |
Русский
English